MARKET

CDMO

CDMO

Avid Bioservices
NASDAQ
9.28
+0.16
+1.75%
Pre Market: 9.20 -0.08 -0.86% 08:54 05/21 EDT
OPEN
9.12
PREV CLOSE
9.12
HIGH
9.35
LOW
8.96
VOLUME
8.96K
TURNOVER
0
52 WEEK HIGH
19.97
52 WEEK LOW
4.071
MARKET CAP
589.09M
P/E (TTM)
-32.6531
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at CDMO last week (0513-0517)?
Weekly Report · 1d ago
Avid Bioservices: A Unique Growth Story With Many Tailwinds And Catalysts
Avid Bioservices, Inc. Has an economic moat with a mission-critical role in drug development. The company has a record revenue-generating capacity and is transitioning to a pure-play biologics CDMO. Avid has a unique growth story with many tailwinds and potential catalysts.
Seeking Alpha · 5d ago
Weekly Report: what happened at CDMO last week (0506-0510)?
Weekly Report · 05/13 09:42
Craig-Hallum Sticks to Their Buy Rating for Avid Bioservices (CDMO)
TipRanks · 05/08 12:59
Avid Bioservices to Participate at Upcoming Investor Conferences
Avid Bioservices, Inc. Will participate at two upcoming investor conferences. The company provides high quality development and manufacturing services to biotechnology and pharmaceutical companies. Nick Green, president and chief executive officer, will be featured speaker at the RBC Capital Markets 2024 Global Healthcare Conference.
Barchart · 05/07 15:05
Avid Bioservices Currently Up 11 Consecutive Days, on Track for Longest Winning Streak on Record -- Data Talk
Avid Bioservices, Inc. Is currently at $8.37, up $0.12 or 1.45%. Currently up 11 consecutive days; up 30.99% over this period -- Longest winning streak on record. Down 98.29% from its all-time closing high of $490.00 on March 7, 2000.
Dow Jones · 05/06 15:33
Weekly Report: what happened at CDMO last week (0429-0503)?
Weekly Report · 05/06 09:45
Avid Bioservices Price Target Raised to $8.00/Share From $7.00 by RBC Capital
Dow Jones · 04/30 17:18
More
About CDMO
Avid Bioservices, Inc. is a contract development and manufacturing organization (CDMO). The Company provides a range of services from process development to Current Good Manufacturing Practices (CGMP) clinical and commercial manufacturing of biologics for the biotechnology and biopharmaceutical industries. It operates in a single segment, which is contract manufacturing and development services. The Company’s services include clinical and commercial product manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The Company also provides a variety of process development services, including upstream and downstream development and optimization, analytical methods development, testing and characterization. It provides fully integrated and customized biomanufacturing services that support its customers from the early preclinical stage to commercial launch and supply.

Webull offers Avid Bioservices Inc stock information, including NASDAQ: CDMO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDMO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CDMO stock methods without spending real money on the virtual paper trading platform.